IP Library Granted Patent US 8,268,984
Granted Patent B2
US 8,268,984 · App. 12/438,992 · Granted Sep 18, 2012

Detection of

Assignee: Bio-Rad Innovations
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,984
App. No.
12/438,992
Granted
Sep 18, 2012
Kind
B2
Abstract

The invention relates to the detection of Salmonella by nucleic acid amplification. The invention provides primer and probe oligonucleotides that can be used in multiplex to detect Salmonella in real-time amplification. The oligonucleotides of the invention detect all group I serovars, and have an increased Salmonella detection range: they enable to cover the seven Salmonella groups. They also have an increased sensitivity, without loss in specificity.

Claims (56)

1. A set of oligonucleotides, which comprises:

an oligonucleotide, the sequence of which consists of SEQ ID NO: 2,

an oligonucleotide, the sequence of which consists of SEQ ID NO: 4,

an oligonucleotide, the sequence of which consists of SEQ ID NO: 3, and

an oligonucleotide, the sequence of which consists of SEQ ID NO: 1.

2. The set of claim 1 , which further comprises at least one of the following oligonucleotides:

I) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, and

II) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, which is linked to:

at least one detection label and/or

two complementary adaptor nucleotide sequences of 3 to 10 nucleotides, one of said adaptor sequences being linked at the 5′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof, the other of said adaptor sequences being linked at the 3′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof.

3. A set of oligonucleotides, which comprises an oligonucleotide, the sequence of which consists of SEQ ID NO: 4 and at least one of the following oligonucleotides:

I) an oligonucleotide, the sequence of which consists of SEQ ID NO: 2,

II) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof,

III) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, which is linked to:

at least one detection label and/or

to two complementary adaptor nucleotide sequences of 3 to 10 nucleotides, one of said adaptor sequences being linked at the 5′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof, the other of said adaptor sequences being linked at the 3′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof,

IV) an oligonucleotide, the sequence of which consists of SEQ ID NO: 3, and

V) an oligonucleotide, the sequence of which consists of SEQ ID NO: 1.

4. A set of oligonucleotides, which comprises an oligonucleotide, the sequence of which consists of SEQ ID NO: 4, an oligonucleotide, the sequence of which consists of SEQ ID NO: 2 and at least one of the following oligonucleotides:

I) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, and

II) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, which is linked to:

at least one detection label and/or

two complementary adaptor nucleotide sequences of 3 to 10 nucleotides, one of said adaptor sequences being linked at the 5′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof, the other of said adaptor sequences being linked at the 3′ end of said oligonucleotide of SEQ ID NO: 5 or complementary sequence thereof.

5. A set of oligonucleotides, which comprises an oligonucleotide, the sequence of which consists of SEQ ID NO: 4 and an oligonucleotide, the sequence of which consists of SEQ ID NO: 2.

6. A set of oligonucleotides, which comprises an oligonucleotide, the sequence of which consists of SEQ ID NO: 4 and at least one of the following oligonucleotides:

I) an oligonucleotide, the sequence of which consists of SEQ ID NO: 2,

II) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, and

III) an oligonucleotide, the sequence of which consists of SEQ ID NO: 5 or of the complementary sequence thereof, which is linked to:

at least one detection label and/or

two complementary adaptor nucleotide sequences of 3 to 10 nucleotides, one of said adaptor sequences being linked at the 5′ end of said oligonucleotide of SEQ ID NO: 5, the other of said adaptor sequences being linked at the 3′ end of said oligonucleotide of SEQ ID NO: 5.

7. The set of any one of claims 4 , 5 and 6 , which further comprises at least one oligonucleotide selected from the group consisting of a sequence which consists of SEQ ID NO: 1 and a sequence which consists of SEQ ID NO: 3.

8. The set of any one of claims 3 , 4 , 2 and 6 which comprises the oligonucleotide, the sequence of which consists of SEQ ID NO: 5, or of the complementary oligonucleotide thereof.

9. The set of any one claims 3 , 4 , 2 and 6 , wherein the sequence of said two complementary adaptor nucleotide sequences of 3 to 10 nucleotides consist of CGCGAC and GTCGCG, respectively.

10. An amplification mix, which comprises:

at least one set of oligonucleotides of any one of claims 1 , 3 , 4 , 2 , 5 and 6 .

11. A kit, which comprises:

at least one set of oligonucleotides of any one of claims 1 , 3 , 4 , 2 , 5 and 6 .

12. The kit of claim 11 , which further comprises at least one among the following elements:

at least one nucleic acid extraction solution,

at least one DNA polymerase,

at least one dNTP,

at least one buffer having a pH adapted to the polymerase activity of said at least one DNA polymerase,

at least one instruction leaflet advising of performing a real-time multiplex amplification, to detect Salmonella,

buffered peptone water.

13. A process for the detection of Salmonella in a sample, which comprises:

optionally, homogenizing said sample,

optionally, incubating said sample, or said homogenized sample, in buffered peptone water for 18±2 hours,

optionally, extracting the nucleic acids from said sample, or from said homogenized sample, or from the pellet recovered by centrifugation of said peptone-incubated sample,

submitting said sample or homogenized sample or pellet, or a nucleic acid extract thereof, to nucleic acid amplification using the four oligonucleotides contained in the set of claim 1 , as primers,

detecting whether an amplicon has been, or is, produced by said nucleic acid amplification,

whereby a positive detection is indicative of the fact that at least one Salmonella is present in said sample.

14. The process of claim 13 , wherein said sample or said homogenized sample is not incubated in buffered peptone water for 18±2 hours.

15. The process of claim 13 , wherein said amplicon detection comprises using as a probe the oligonucleotide, the sequence of which consists of SEQ ID NO: 5, or of the complementary oligonucleotide thereof.

16. The process of claim 15 , wherein said amplicon detection further comprises using at least one other oligonucleotide, which is specific of one or several Salmonella strain(s) and/or serovar(s) and/or subspecies and/or species, as a probe.

17. The process of claim 13 , which is a real-time amplification process.

18. A process to check the safety of products that are intended for human and/or animal consumption, or the safety of a food and/or beverage product, or of a product that is used in the manufacture of a food and/or beverage product, which comprises the detection of Salmonella , wherein said detection of Salmonella is made by the process of claim 13 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2019
From: BIO-RAD INNOVATIONS
To: BIO-RAD EUROPE GMBH
Reel/Frame 049122/0754 →
CHANGE OF NAME Recorded Aug 9, 2011
From: BIO-RAD PASTEUR
To: BIO-RAD INNOVATIONS
Reel/Frame 026722/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2009
From: TOURNIAIRE, JEAN-PHILIPPE
To: BIO-RAD PASTEUR
Reel/Frame 022318/0941 →
Priority Claims (1)
EP 06291388 · Sep 1, 2006 · regional
Continuity (1)
Related Publication 20090298076A1 · Dec 3, 2009